Similarly, suppressed BMP2 in HepG2 cells inhibits tumor development, progression, and angiogenesis in HCC via inactivating the MAPK/p38 signaling pathway (Feng et al., 2019). This evidence concerns the gene BMP2 and hepatocellular carcinoma.